Documents Biosimilar - A Purview

BIOSIMILAR: A PURVIEW IP & Communication BIOLOGICS • Biopharmaceuticals such as therapeutic proteins, DNA vaccines, monoclonal antibodies, fusion proteins, gene therapy,…

Business The Biologics Inflection Point: Managing The Risk From Biosimilar Competition

1. L E K . C O ML.E.K. Consulting / Executive Insights EXECUTIVE INSIGHTS INSIGHTS @ WORKTM VOLUME XVI, ISSUE 10 The Biologics Inflection Point: Managing The Risk From Biosimilar…